Overall rank by patents
#8,259
of 50,000 tracked assignees
USPTO PatentsView assignee record - 39 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
According to USPTO PatentsView, Neovasc ranks #8,259 of 50,000 tracked US assignees by granted-patent volume, with 39 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R8259 · Foreign Corporation #8,259 · 39 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Newpark MATS & Integrated Services Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Industry Academic Co… · near
44 score
Leuze + KG · near
44 score
Neovasc Tiara · this assignee
44 score
Unimatec · near
44 score
Entrust Datacard · near
44 score
3D Lighting Innovati… · lowest
7 score
What this shows Neovasc Tiara Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-DENSE, TYPE-FRNCORP, VEL-SURGE, BOOK-FULL. Volume places it #8,259 of 50,000; Innovation Score 44.4/100 sits in the top 26% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Newpark MATS & Integrated Services Llc (±0 grants).
Neovasc Tiara Inc. has been granted 39 US utility patents between 2016 and 2025, placing Neovasc Tiara Inc. at #8,259 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.9 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Neovasc Tiara Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Neovasc sits between Newpark MATS & Integrated Services Llc (39 patents, rank #8,260) and Oklahoma Medical Research Foundation (39 patents, rank #8,268) - the closest US assignees by grant volume. The composite Innovation Score of 44.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 23 grants, compared with 14 in the 2015–2019 window, a +64% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Neovasc Tiara Inc.'s 20.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 4 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NEWPARK MATS & INTEGRATED SERVICES LLC
39 patents
NIPPON PISTON RING CO., LTD.
39 patents
NITTOH INC.
39 patents
NOVADELTA—COMÉRCIO E INDÚSTRIA DE CAFÉS, LDA
39 patents
Nexa3D Inc.
39 patents
NuWave LLC
39 patents
OXFORD INSTRUMENTS NANOTECHNOLOGY TOOLS LIMITED
39 patents
Oklahoma Medical Research Foundation
39 patents
Neovasc Tiara Inc.
39 patents
What this shows Neovasc holds 39 patents at rank #8,264, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,264 in granted patent volume.
Other assignees with the most granted patents in Neovasc's primary technology class.
Two PlainPatent-derived peer sets for Neovasc, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (44 here).
Neovasc's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 4 | 10.3% |
| 2017 | 4 | 10.3% |
| 2018 | 1 | 2.6% |
| 2019 | 5 | 12.8% |
| 2020 | 4 | 10.3% |
| 2021 | 1 | 2.6% |
| 2022 | 7 | 17.9% |
| 2023 | 5 | 12.8% |
| 2024 | 6 | 15.4% |
| 2025partial year | 2 | 5.1% |
Top 4 of 4 technology areas
Overall rank by patents
#8,259
of 50,000 tracked assignees
44.4 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.